| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Linling Jiang, Yuqi Cheng, Hongyan Jiang, Jian Xu, Jin Lu, Zonglin Shen, Yi Lu, Fang Liu, Luqiong Li, Xiufeng X. Association between abnormal serum myelin-specific protein levels and white matter integrity in first-episode and drug-naïve patients with major depressive disorder. Journal of affective disorders. vol 232. 2018-08-31. PMID:29477585. |
the current study aimed to investigate the myelin oligodendrocyte glycoprotein (mog) and myelin-associated glycoprotein (mag) levels and their correlations with wm integrity in first-episode, drug-naïve mdd patients. |
2018-08-31 |
2023-08-13 |
Not clear |
| Malabendu Jana, Supurna Ghosh, Kalipada Paha. Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis. Neurochemical research. vol 43. issue 2. 2018-08-16. PMID:29143164. |
rns60, but not normal saline (ns), rns10.3 (tcp-modified saline without excess oxygen) or pns60 (saline containing excess oxygen without tcp modification), stimulated the expression of myelin-specific genes and proteins (myelin basic protein, mbp; myelin oligodendrocyte glycoprotein, mog and proteolipid protein, plp) in primary mouse oligodendroglia and mixed glial cells. |
2018-08-16 |
2023-08-13 |
mouse |
| Maciej Jurynczyk, Fay Probert, Tianrong Yeo, George Tackley, Tim D W Claridge, Ana Cavey, Mark R Woodhall, Siddharth Arora, Torsten Winkler, Eric Schiffer, Angela Vincent, Gabriele DeLuca, Nicola R Sibson, M Isabel Leite, Patrick Waters, Daniel C Anthony, Jacqueline Palac. Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease. Acta neuropathologica communications. vol 5. issue 1. 2018-08-16. PMID:29208041. |
the overlapping clinical features of relapsing remitting multiple sclerosis (rrms), aquaporin-4 (aqp4)-antibody (ab) neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein (mog)-ab disease mean that detection of disease specific serum antibodies is the gold standard in diagnostics. |
2018-08-16 |
2023-08-13 |
Not clear |
| Eva-Maria Hennes, Matthias Baumann, Christian Lechner, Kevin Rostás. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice. Neuropediatrics. vol 49. issue 1. 2018-08-14. PMID:28859212. |
myelin oligodendrocyte glycoprotein (mog) antibodies (abs) are present in one third of all children with an acute demyelinating syndrome (ads). |
2018-08-14 |
2023-08-13 |
Not clear |
| Güneş Altıokka-Uzun, Ece Erdağ, Betül Baykan, John Tzartos, Duygu Gezen-Ak, Bedia Samancı, Erdinç Dursun, Paraskevi Zisimopoulou, Katerina Karagiorgou, Christos Stergiou, Erdi Şahin, Esme Ekizoğlu, Murat Kürtüncü, Erdem Tüzü. Glial and neuronal antibodies in patients with idiopathic intracranial hypertension. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 38. issue 10. 2018-07-30. PMID:28733756. |
we aimed to investigate the antibodies against optic neuritis-associated glial antigens, aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) and uncharacterized neuronal membrane antigens in iih patients. |
2018-07-30 |
2023-08-13 |
human |
| Guixian Zhao, Qian Chen, Yongheng Huang, Zhenxin Li, Xinghuai Sun, Ping Lu, S Yan, Min Wang, Guohong Tia. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China. Journal of neurology. vol 265. issue 1. 2018-07-27. PMID:29101456. |
qualitative and quantitative visual outcomes of asian optic neuritis (on) patients with seropositive myelin oligodendrocyte glycoprotein (mog) antibodies remain unknown. |
2018-07-27 |
2023-08-13 |
Not clear |
| Evangelia Kesidou, Olga Touloumi, Roza Lagoudaki, Evangelia Nousiopoulou, Paschalis Theotokis, Kyriaki-Nepheli Poulatsidou, Marina Boziki, Evangelia Kofidou, Nickoleta Delivanoglou, Fani Minti, Georgios Hadjigeorgiou, Nikolaos Grigoriadis, Constantina Simeonido. Humoral response in experimental autoimmune encephalomyelitis targets neural precursor cells in the central nervous system of naive rodents. Journal of neuroinflammation. vol 14. issue 1. 2018-07-27. PMID:29162133. |
therefore, we investigated the potential affinity of myelin oligodendrocyte glycoprotein (mog)-induced humoral response(s) to npcs. |
2018-07-27 |
2023-08-13 |
Not clear |
| Bandana Shrestha, Xi Jiang, Shujun Ge, Debayon Paul, Peter Chianchiano, Joel S Pachte. Spatiotemporal resolution of spinal meningeal and parenchymal inflammation during experimental autoimmune encephalomyelitis. Neurobiology of disease. vol 108. 2018-07-23. PMID:28844788. |
experimental autoimmune encephalomyelitis (eae) induced by active immunization of c57bl/6 mice with peptide from myelin oligodendrocyte protein (mog |
2018-07-23 |
2023-08-13 |
mouse |
| Andreas Warnecke, Sonja Abele, Sravani Musunuri, Jonas Bergquist, Robert A Harri. Scavenger Receptor A Mediates the Clearance and Immunological Screening of MDA-Modified Antigen by M2-Type Macrophages. Neuromolecular medicine. vol 19. issue 4. 2018-07-18. PMID:28828577. |
in this study, we investigated the uptake of malondialdehyde (mda)-modified myelin oligodendrocyte glycoprotein (mog) in the context of lipid peroxidation and its implications in cns autoimmunity. |
2018-07-18 |
2023-08-13 |
Not clear |
| Yoshio Bando, Yoshiaki Hagiwara, Yasuhiro Suzuki, Kosuke Yoshida, Yoko Aburakawa, Takashi Kimura, Chisato Murakami, Miyuki Ono, Tatsuhide Tanaka, Ying-Ping Jiang, Branka Mitrovi, Hiroki Bochimoto, Osamu Yahara, Shigetaka Yoshid. Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis. Glia. vol 66. issue 2. 2018-07-18. PMID:29086442. |
interestingly, anti-mog (myelin oligodendrocyte glycoprotein) autoantibody was also detected in the cerebrospinal fluid (csf) and spinal cord on day 3 after mog immunization. |
2018-07-18 |
2023-08-13 |
mouse |
| B M Escribano, E Luque, M Aguilar-Luque, M Feijóo, J Caballero-Villarraso, L A Torres, V Ramirez, F I García-Maceira, E Agüera, A Santamaria, I Túne. Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis. European journal of pharmacology. vol 815. 2018-07-05. PMID:28939293. |
experimental autoimmune encephalomyelitis (eae) as a model of multiple sclerosis (ms) was induced by the myelin oligodendrocyte glycoprotein (mog), whose effects were quantified by examining the changes in: clinical score, lipid peroxidation products, carbonylated proteins, glutathione system, tumor necrosis factor alpha (tnfα), and lipopolysaccharide membrane bacteria (lps). |
2018-07-05 |
2023-08-13 |
Not clear |
| Patrick Peschl, Kathrin Schanda, Bleranda Zeka, Katherine Given, Denise Böhm, Klemens Ruprecht, Albert Saiz, Andreas Lutterotti, Kevin Rostásy, Romana Höftberger, Thomas Berger, Wendy Macklin, Hans Lassmann, Monika Bradl, Jeffrey L Bennett, Markus Reind. Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination. Journal of neuroinflammation. vol 14. issue 1. 2018-06-18. PMID:29070051. |
antibodies to the myelin oligodendrocyte glycoprotein (mog) are associated with a subset of inflammatory demyelinating diseases of the central nervous system such as acute disseminated encephalomyelitis and neuromyelitis optica spectrum disorders. |
2018-06-18 |
2023-08-13 |
human |
| Chaitali P Basole, Rebecca K Nguyen, Katie Lamothe, Amanda Vang, Robert Clark, George S Baillie, Paul M Epstein, Stefan Brock. PDE8 controls CD4 Cellular signalling. vol 40. 2018-06-13. PMID:28851628. |
the highly pde8-selective enzymatic inhibitor pf-04957325 suppresses adhesion of in vivo myelin oligodendrocyte glycoprotein (mog) activated inflammatory cd4 |
2018-06-13 |
2023-08-13 |
Not clear |
| Masataka Nakamura, Yuko Iwasaki, Toshiyuki Takahashi, Kimihiko Kaneko, Ichiro Nakashima, Takenobu Kunieda, Satoshi Kaneko, Hirofumi Kusak. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. Multiple sclerosis and related disorders. vol 17. 2018-06-07. PMID:29055448. |
myelin oligodendrocyte glycoprotein (mog) antibody-positive optic neuritis (on) and myelitis are recognized as important differential diagnosis of aquaporin-4 (aqp4) antibody-positive neuromyelitis optica (nmo)/nmo spectrum disorder (nmosd). |
2018-06-07 |
2023-08-13 |
Not clear |
| Yael Hacohen, Thomas Rossor, Kshitij Mankad, Wk 'Kling' Chong, Andrew Lux, Evangeline Wassmer, Ming Lim, Frederik Barkhof, Olga Ciccarelli, Cheryl Hemingwa. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease. Developmental medicine and child neurology. vol 60. issue 4. 2018-05-21. PMID:29288492. |
to review the demographics and clinical and paraclinical parameters of children with myelin oligodendrocyte glycoprotein (mog) antibody-associated relapsing disease. |
2018-05-21 |
2023-08-13 |
Not clear |
| J P Vieira, J Sequeira, M J Brit. Postinfectious Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis. Journal of child neurology. vol 32. issue 12. 2018-05-14. PMID:28820014. |
anti-aquaporin 4 antibody was negative and anti-myelin oligodendrocyte glycoprotein antibody (mog) positive. |
2018-05-14 |
2023-08-13 |
human |
| Masahiro Nishiyama, Hiroaki Nagase, Masaaki Matsumoto, Kazumi Tomioka, Hiroyuki Awano, Tsukasa Tanaka, Daisaku Toyoshima, Kyoko Fujita, Azusa Maruyama, Yoshinobu Oyazato, Keisuke Saeki, Kazuhiro Shiraishi, Satoshi Takada, Kimihiko Kaneko, Toshiyuki Takahashi, Ichiro Nakashima, Kazumoto Iijim. Clinical features in very early-onset demyelinating disease with anti-MOG antibody. Brain & development. vol 39. issue 9. 2018-05-08. PMID:28551039. |
the clinical features of patients with very early-onset acquired demyelinating syndrome (ads) with the anti-myelin oligodendrocyte glycoprotein (mog) antibody are unknown. |
2018-05-08 |
2023-08-13 |
Not clear |
| Marc-André Lécuyer, Olivia Saint-Laurent, Lyne Bourbonnière, Sandra Larouche, Catherine Larochelle, Laure Michel, Marc Charabati, Michael Abadier, Stephanie Zandee, Neda Haghayegh Jahromi, Elizabeth Gowing, Camille Pittet, Ruth Lyck, Britta Engelhardt, Alexandre Pra. Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis. Proceedings of the National Academy of Sciences of the United States of America. vol 114. issue 4. 2018-04-12. PMID:28069965. |
in the present study, we found that alcam knockout (ko) mice developed a more severe myelin oligodendrocyte glycoprotein (mog) |
2018-04-12 |
2023-08-13 |
mouse |
| Nicholas S R Sanderson, Maria Zimmermann, Luca Eilinger, Céline Gubser, Nicole Schaeren-Wiemers, Raija L P Lindberg, Stephanie K Dougan, Hidde L Ploegh, Ludwig Kappos, Tobias Derfus. Cocapture of cognate and bystander antigens can activate autoreactive B cells. Proceedings of the National Academy of Sciences of the United States of America. vol 114. issue 4. 2018-04-09. PMID:28057865. |
autoantibodies against myelin oligodendrocyte glycoprotein (mog) are associated with autoimmune central nervous system diseases like acute disseminated encephalomyelitis (adem). |
2018-04-09 |
2023-08-13 |
mouse |
| Carsten Tue Berg, Reza Khorooshi, Nasrin Asgari, Trevor Owen. Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination. Journal of neuroinflammation. vol 14. issue 1. 2018-04-03. PMID:28646890. |
antibodies with specificity for myelin oligodendrocyte glycoprotein (mog) are implicated in multiple sclerosis and related diseases. |
2018-04-03 |
2023-08-13 |
Not clear |